Abstract:As a compound derived from cruciferous vegetables, sulforaphane showed promise in depression treatment. This study aimed to investigate its effects on the hypothalamic-pituitary-adrenal (HPA) axis and glucocorticoid receptor (GR) function using a chronic corticosterone (CORT)-induced cell and mouse model. We evaluated the effects of sulforaphane on depression-like behavior, pathology, hormone levels, inflammation, GR expression, and hippocampal proteins. Additionally, molecular docking was conducted to explore sulforaphane's binding interaction with GR. Results showed that CORT exposure reduced GR expression, increased stress hormones and pro-inflammatory cytokines, decreased BDNF-related pathway activity, and intensified GR nuclear translocation. Sulforaphane administration reversed these effects, improving depression-like behavior. Molecular docking showed sulforaphane fitting into the GR pocket, forming hydrogen bonds and hydrophobic interactions, with a binding free energy of -4.92 kcal/mol. These findings suggest that sulforaphane exerted neuroprotective and antidepressant effects by modulating GR expression and mitigating inflammation-induced apoptosis and impaired neuroplasticity, likely mediated through the NF-KB and ERK/CREB/BDNF pathways.

Protective Effect of Sulforaphane Against Depressive Behavior in Mice Through Glucocorticoid Receptor Antagonism